NewsBenzinga팔리세이드 바이오, 크론병 치료제 PALI-2108에 대한 임상시험용 신약 신청서 FDA 승인 획득···내년 1분기 첫 참가자 등록 예정 팔리세이드 바이오, 크론병 치료제 PALI-2108에 대한 임상시험용 신약 신청서 FDA 승인 획득···내년 1분기 첫 참가자 등록 예정 Benzinga 2026.09.22 12:36 (GMT+0) Open on Benzinga Other news Oracle, Chipotle, Verizon, GameStop and Securitize Corp: Why These 5 Stocks Are on Investors' Radars Today US SOL spot ETFs see single-day net outflow of $3.3209 million VC firm USV raises $900 million new fund focused on early-stage investments in AI and other sectors Arthur Hayes: Bull markets must overcome many fears at the start, and the "money-printing wave" will drive asset prices to surge Jump Crypto Stakes $49.81 Million Worth of SOL Here's How Much $1000 Invested In Shopify 10 Years Ago Would Be Worth Today
Oracle, Chipotle, Verizon, GameStop and Securitize Corp: Why These 5 Stocks Are on Investors' Radars Today
Arthur Hayes: Bull markets must overcome many fears at the start, and the "money-printing wave" will drive asset prices to surge
